In a landmark moment for public healthcare across Central India, AIIMS Bhopal formally launched its lung transplant programme on Saturday, March 28, 2026 — becoming the first and only government hospital in the region to offer all four major organ transplants under one roof and entirely free of cost. The milestone places Bhopal on the national medical map alongside institutions in Delhi and Chandigarh, and brings life-saving surgical care within reach of millions of patients across Madhya Pradesh, Chhattisgarh, and neighbouring states who previously had no affordable option.

What Changed Today

Until today, patients in Central India requiring a lung transplant faced a brutal choice: travel to private hospitals in Mumbai, Delhi, or Chennai and arrange between Rs 25 lakh and Rs 35 lakh for the procedure — a sum entirely out of reach for most families — or simply wait and deteriorate. AIIMS Bhopal's lung transplant programme changes that equation entirely. The procedure will be performed free of cost, consistent with the institute's existing approach to heart, kidney, and bone marrow transplants. Post-surgical medications and follow-up care are also expected to be provided at no charge, removing the financial barrier at every stage of treatment.

SOTTO Inspection Clears the Path

The regulatory pathway to this launch was set in motion when the State Organ and Tissue Transplant Organisation conducted a formal site inspection at AIIMS Bhopal to assess its readiness for lung transplant operations. The SOTTO team examined the institute's infrastructure, operation theatre capacity, ICU facilities, post-transplant care protocols, and the qualifications and training of its surgical team. Minor deficiencies identified during the initial inspection were subsequently addressed by the hospital administration. With the inspection report submitted and government approval received, the institute was cleared to formally launch the programme.

AIIMS Bhopal's Public Relations Officer Dr Ketan Mehra had earlier confirmed that kidney and heart transplants were already being performed at the institute, and that lung transplants were the natural next step once regulatory clearance was obtained.

Doctors Trained in Chennai

Lung transplants demand a very specific surgical skill set. Unlike kidney transplants, which are performed by general transplant surgeons, lung transplant procedures require cardiovascular surgeons with specialised training. Keeping this in mind, a dedicated team of doctors from AIIMS Bhopal underwent intensive training at a specialised centre in Chennai, where they received hands-on instruction in the complex techniques involved in both heart and lung transplant operations. That training investment is now paying off — the surgical team is certified and operationally ready.

A Transplant Programme Built Over Two Years

Today's launch did not happen overnight. AIIMS Bhopal has been building its transplant programme steadily and systematically since 2024. In January 2025, the institute performed Madhya Pradesh's first ever successful heart transplant — a procedure that demonstrated its capacity to handle the most technically demanding organ surgeries. Since then, AIIMS Bhopal has completed three heart transplants and seventeen kidney transplants, accumulating a foundation of institutional expertise and post-operative management experience that directly supports the lung transplant programme.

With lung transplants now added, AIIMS Bhopal becomes the only government institution in Central India to offer heart, kidney, bone marrow, and lung transplants — all under one roof and at zero cost to the patient.

Infrastructure Expanding in Step

The launch of the lung transplant programme is part of a wider infrastructure expansion that AIIMS Bhopal has outlined for 2026. A dedicated transplant operation theatre — designed separately from the general surgical OTs and built to meet the sterile, infection-controlled standards that organ transplants require — is being commissioned this year. This specialised OT will allow all four categories of transplants to be performed under optimal conditions, reducing waiting times and improving infection management outcomes.

Beyond transplants, the institute is also installing Gamma Knife technology for the non-surgical treatment of brain tumours and complex neurological conditions using precision radiation. A PET Scan machine for faster and more accurate cancer diagnosis is also being added. A new four-storey ICU building is under construction adjacent to the cancer block to handle the growing volume of critical care patients the institute is attracting from across the region.

What This Means for Patients

The human stakes behind this announcement are significant. A lung transplant is the last medical option available to patients with chronic, end-stage respiratory disease — conditions such as pulmonary fibrosis, where lung tissue progressively scars, or advanced COPD, where airways are irreversibly damaged. For these patients, transplant is not an elective procedure — it is the only remaining path to survival.

In India, the overwhelming majority of lung transplants have historically been performed at private hospitals in southern India, at costs that place the procedure beyond the reach of all but the wealthiest patients. Follow-up immunosuppressive medications, which must be taken lifelong to prevent organ rejection, add several lakhs more to the annual financial burden. For a family from a small town in Madhya Pradesh or Chhattisgarh, that total cost is simply impossible to arrange.

AIIMS Bhopal's free lung transplant programme removes that barrier. It does not make the procedure easy — organ availability remains a persistent challenge across India, and the post-operative medical demands are significant — but it removes the financial wall that was, for most families, the single greatest obstacle.

Central India's Medical Landscape Shifts

Today's launch is a defining moment not just for AIIMS Bhopal but for the entire public healthcare landscape of Central India. For decades, residents of Madhya Pradesh and Chhattisgarh have lived in a region without a single government facility capable of performing a lung transplant. That gap — invisible in policy documents but devastating in its human consequences — closes today.